Immunotherapy rechallenge in gastric cancer: resistance mechanisms, molecular stratification, and precision decision-making

Background/objectivesImmune checkpoint inhibitors (ICIs) have changed the treatment landscape of advanced gastric cancer (GC). However, acquired resistance remains common. For patients who initially benefit and later progress, immunotherapy rechallenge is biologically plausible but still investigati...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yu-cai Jiang, Lin-lin Zheng, Ming-gui Fu, Bi-jin Zheng
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-05-01
Col·lecció:	Frontiers in Immunology
Matèries:	gastric cancer immune checkpoint inhibitor immunotherapy molecular stratification precision therapy rechallenge
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1820652/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!